IO Biotech to participate in panel discussion at Biotech Showcase in San Francisco on January 7th

Jan 05 2019

Copenhagen, Denmark – January 5, 2019:  IO Biotech’s CEO, Mai-Britt Zocca, is to participate in the panel discussion “Investing in Next Gen Immunotherapies: Moving the Checkpoint Inhibitors to the Next Level” at Biotech Showcase in San Francisco on January 7, 2019 during the JPM week.